Cite
Sellner L, Schetelig J, Koster L, et al. Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey. Bone Marrow Transplant. 2021;56(12):3108doi: 10.1038/s41409-021-01490-9.
Sellner, L., Schetelig, J., Koster, L., Choi, G., Blaise, D., Beelen, D., Schianca, F. C., Passweg, J., Schanz, U., Gyan, E., Sora, F., Kröger, N., Wulf, G. G., Van Gorkom, G., Mayer, J., Orvain, C., Bourhis, J. H., Jindra, P., Potter, V., Zallio, F., Vandenberghe, E., Robinson, S., Hayden, P. J., Yakoub-Agha, I., Montoto, S., Dreger, P. (2021). Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey. Bone marrow transplantation, 56(12), 3108. https://doi.org/10.1038/s41409-021-01490-9
Sellner, Leopold, et al. "Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey." Bone marrow transplantation vol. 56,12 (2021): 3108. doi: https://doi.org/10.1038/s41409-021-01490-9
Sellner L, Schetelig J, Koster L, Choi G, Blaise D, Beelen D, Schianca FC, Passweg J, Schanz U, Gyan E, Sora F, Kröger N, Wulf GG, Van Gorkom G, Mayer J, Orvain C, Bourhis JH, Jindra P, Potter V, Zallio F, Vandenberghe E, Robinson S, Hayden PJ, Yakoub-Agha I, Montoto S, Dreger P. Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey. Bone Marrow Transplant. 2021 Dec;56(12):3108. doi: 10.1038/s41409-021-01490-9. PMID: 34621022.
Copy
Download .nbib